Listen Now
Topics Covered
- Overview of CAR-T Cell Therapy
- Understanding CARs – Chimeric Antigen Receptors
- When to Consider CAR-T Cell Therapy as a Treatment Option for Lymphoma
- Clinical Trials for CAR-T Cell Therapy
- Discussion of CAR-T Cell Therapy
- Managing Potential Treatment Side Effects
- Specific Examples of How CAR-T Cell Therapy May Contribute to Your Lymphoma Treatment Choices
- Key Questions to Ask Your Health Care Team about CAR-T Cell Therapy
- The Benefits of CAR-T Cell Therapy
- Follow-Up Care: What to Expect
- Questions for Our Panel of Experts
Our Panel of Experts
Nancy Bartlett, MD
Koman Chair in Medical Oncology, Professor, Department of Medicine, Oncology Division/Medical Oncology, Washington University School of Medicine in St. Louis
M. Lia Palomba, MD
Hematologist-Oncologist, Memorial Sloan Kettering Cancer Center, Associate Professor of Clinical Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College
Peggy Ann Torney
Chief Strategy, Communications and Engagement Officer, Lymphoma Research Foundation
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
(89.1 KB)
Workshop Date
This workshop was originally recorded on November 16, 2018.